×
For best experience we recommend to activate Javascript in your browser.
NG2 antibody (AA 559-776)
This Rabbit Polyclonal antibody specifically detects NG2 in WB, IHC, IP and ICC. It exhibits reactivity toward Human.
Quick Overview for NG2 antibody (AA 559-776) (ABIN7614229)
Target
See all NG2 (MCSP) Antibodies
NG2 (MCSP)
(Melanoma Associated Chondroitin Sulfate Proteoglycan (MCSP))
Reactivity
All reactivities for NG2 antibodies
Human
Host
All hosts for NG2 antibodies
Rabbit
Clonality
All clonalities for NG2 antibodies
Polyclonal
Conjugate
All conjugates for NG2 antibodies
This NG2 antibody is un-conjugated
Application
All applications for NG2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-NG2 Antibody
(hide)
Binding Specificity
All epitopes for NG2 antibodies
AA 559-776
Purpose
Chondroitin Sulfate Proteoglycan 4 (CSPG4) Polyclonal Antibody
Sequence
His559~Pro776
Characteristics
The Chondroitin Sulfate Proteoglycan 4 (CSPG4) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for NG2
(hide)
Target
NG2 (MCSP)
(Melanoma Associated Chondroitin Sulfate Proteoglycan (MCSP))
Alternative Name
CSPG4
Gene ID
1464
UniProt
Q6UVK1
Pathways
Glycosaminoglycan Metabolic Process
Recently viewed
(hide)
Chat with us , powered by LiveChat